Recommendations on the clinical use of bendamustine in lymphoproliferative syndromes and multiple myeloma
Por:
Peñalver FJ, Delgado J, Loscertales J, Sastre JL, Peña A, Olave MT, Osorio S, de la Fuente A, Salar A, Grande C, Pérez Ceballos E, Debén G, Echeveste A, Casado F, de la Rubia J, Lahuerta JJ and Mateos MV
Publicada:
1 may 2016
Ahead of Print:
9 ago 2015
Resumen:
Bendamustine is an increasingly used hybrid alkylating agent that is active in lymphoid neoplasias via a novel mechanism of action. There are some pending questions about its use in clinical practice because of its developmental features. A consensus panel of several leading Spanish hematologists with broad experience in the clinical use of bendamustine has established recommendations for the management and treatment of hematological patients with bendamustine based on available clinical data and theexperience of the participants. These recommendations address the dose and treatment regimen fordifferent clinical indications, the management of toxicity, and support therapy. This article contains the conclusions of this consensus panel, which are intended to serve as guidelines for the use of bendamustine.
Filiaciones:
Peñalver FJ:
Department of Hematology, Hospital Universitario Fundación Alcorcón, Alcorcón, Madrid, Spain
Delgado J:
Department of Hematology, Hospital Clinic, Barcelona, Spain
Loscertales J:
Department of Hematology, Hospital Universitario de La Princesa, Madrid, Spain
Sastre JL:
Department of Hematology, Complexo Hospitalario de Ourense, Ourense, Spain
Peña A:
Department of Hematology, Hospital Universitario San Carlos, Madrid, Spain
Olave MT:
Department of Hematology, Hospital Universitario Lozano Blesa, Zaragoza, Spain
Osorio S:
Department of Hematology, Hospital Universitario Gregorio Marañón, Madrid, Spain
de la Fuente A:
Department of Hematology, MD Anderson Cancer Center, Madrid, Spain
Salar A:
Department of Hematology, Hospital del Mar, Barcelona, Spain
Grande C:
Department of Hematology, Hospital Universitario 12 de Octubre, Madrid, Spain
Pérez Ceballos E:
Department of Hematology, Hospital Universitario Morales Messeguer, Murcia, Spain
Debén G:
Department of Hematology, Complexo Hospitalario de La Coruña, La Coruña, Spain
Echeveste A:
Department of Hematology, Hospital Universitario Donostia, San Sebastián, Spain
Casado F:
Department of Hematology, Hospital Virgen de la Salud, Toledo, Spain
:
Department of Hematology, Hospital Universitario Doctor Peset, Valencia, Spain
Lahuerta JJ:
Department of Hematology, Hospital Universitario 12 de Octubre, Madrid, Spain
Mateos MV:
Department of Hematology, IBSAL-Hospital Universitario de Salamanca, Salamanca, Spain
|